Our experts reflect on the pricing and market access trends that shaped the European Landscape in 20...
Read moreIs the National Institute for Health and Care Excellence (NICE) becoming more efficient in evaluatin...
Read moreThe purpose of this study is to compare the assessments of orphan and non-orphan drugs by NICE.
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWhen making a decision about the approval of a new product NICE (National Institute for Health and C...
Read moreThe Head of Agency Group (HAG) is a recently launched network created by the European Health Technol...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe use of combination therapy is increasingly becoming the standard of care in oncology as cancers ...
Read moreThe IHSI is an independent legal entity, with representatives from eight member countries.
Read more